Stryker Corporation vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? Stryker Corporation trades at $315 (market cap $122.35B), while Vanguard S&P 500 Growth Index Fund ETF trades at $81.59. The key difference: Stryker Corporation pays a 1% dividend while Vanguard S&P 500 Growth Index Fund ETF pays none, and Vanguard S&P 500 Growth Index Fund ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SYK | VOOG | |
|---|---|---|
Market Cap | $122.35B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $403.53 | $85.11 |
52-Week Low | $282.58 | $65.32 |
Enterprise Value | $134.10B | — |
Dividend Yield | 1% | — |
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $319.14, down 0.23% on the day, with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust profitability with 63.83% gross margins and 13.21% net margins. Recent Q1 2026 earnings missed expectations due to a cybersecurity disruption, but management maintained full-year guidance. Analyst consensus remains strongly bullish with a $388.44 price target and 74% buy ratings.
The stock presents a compelling opportunity for long-term investors given its strong fundamentals and innovation pipeline, though near-term technical weakness and competitive pressures warrant caution. Upside potential exists from continued Mako robotics adoption and market share gains, while risks include cybersecurity vulnerabilities and integration challenges from acquisitions.
VOOG, the Vanguard S&P 500 Growth ETF, trades at $80.98, up 0.28% on the day. The technical outlook is bearish with moving averages signaling selling pressure, though oscillators are neutral. Recent news highlights its competitive expense ratio of 0.07% and heavy technology sector concentration, which has driven strong long-term returns but also introduces volatility. A 1:6 stock split occurred on April 21, 2026, and a small dividend is scheduled for June 26, 2026.
The ETF's outlook hinges on the performance of large-cap growth stocks, particularly in technology. Opportunities exist from continued AI-driven growth, but risks include high sector concentration and market sensitivity to tech valuations. Analyst sentiment is generally positive given its low-cost structure and historical performance, though the current bearish technical signal warrants caution.
Trailing returns across standard periods
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Read more on VOOG →